400 related articles for article (PubMed ID: 18600566)
1. Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida K
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
[TBL] [Abstract][Full Text] [Related]
2. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice.
Liu CM; Yang Z; Liu CW; Wang R; Tien P; Dale R; Sun LQ
Gene Ther; 2008 Feb; 15(3):155-60. PubMed ID: 18033313
[TBL] [Abstract][Full Text] [Related]
3. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
[TBL] [Abstract][Full Text] [Related]
4. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
5. [Myostatin blockade therapy for muscular atrophy].
Sunada Y
Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
[TBL] [Abstract][Full Text] [Related]
6. Myostatin is a procachectic growth factor during postnatal myogenesis.
McFarlane C; Sharma M; Kambadur R
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):422-7. PubMed ID: 18542002
[TBL] [Abstract][Full Text] [Related]
7. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
Patel K; Amthor H
Neuromuscul Disord; 2005 Feb; 15(2):117-26. PubMed ID: 15694133
[TBL] [Abstract][Full Text] [Related]
8. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice.
Tang L; Yan Z; Wan Y; Han W; Zhang Y
Muscle Nerve; 2007 Sep; 36(3):342-8. PubMed ID: 17587222
[TBL] [Abstract][Full Text] [Related]
9. The possible role of myostatin in skeletal muscle atrophy and cachexia.
Jespersen J; Kjaer M; Schjerling P
Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
Bartoli M; Poupiot J; Vulin A; Fougerousse F; Arandel L; Daniele N; Roudaut C; Noulet F; Garcia L; Danos O; Richard I
Gene Ther; 2007 May; 14(9):733-40. PubMed ID: 17330087
[TBL] [Abstract][Full Text] [Related]
11. The myostatin gene: physiology and pharmacological relevance.
Joulia-Ekaza D; Cabello G
Curr Opin Pharmacol; 2007 Jun; 7(3):310-5. PubMed ID: 17374508
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
13. [Altered expression of myostatin gene in the progressive muscular dystrophy patients].
Zhang Y; Chen Y; Chen JW; Zhu DH
Yi Chuan Xue Bao; 2005 Aug; 32(8):779-83. PubMed ID: 16231730
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.
Nakatani M; Kokubo M; Ohsawa Y; Sunada Y; Tsuchida K
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E543-53. PubMed ID: 21205933
[TBL] [Abstract][Full Text] [Related]
15. Prolonged absence of myostatin reduces sarcopenia.
Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
[TBL] [Abstract][Full Text] [Related]
16. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass.
Kinouchi N; Ohsawa Y; Ishimaru N; Ohuchi H; Sunada Y; Hayashi Y; Tanimoto Y; Moriyama K; Noji S
Gene Ther; 2008 Aug; 15(15):1126-30. PubMed ID: 18323791
[TBL] [Abstract][Full Text] [Related]
17. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
18. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
[TBL] [Abstract][Full Text] [Related]
19. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
Tsuchida K
Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572
[TBL] [Abstract][Full Text] [Related]
20. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
Matsakas A; Diel P
Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
